Faron Pharmaceuticals Oy (FARN) — Capital Reinvestment Ratio

Latest as of January 2015: 0.21x

Faron Pharmaceuticals Oy (FARN) has a Capital Reinvestment Ratio of 0.21x as of January 2015, meaning it reinvests 0% of its operating cash flow (GBX178.50) in capital expenditures (GBX38.00). See Faron Pharmaceuticals Oy (FARN) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.21x
Capex / Operating Cash Flow

Operating Cash Flow

GBX178.50
GBX

Capital Expenditures

GBX38.00
GBX

Data as of

Jan 2015
Most recent filing

Annual Capital Reinvestment Ratio for Faron Pharmaceuticals Oy (None–None)

Year-by-year Capital Reinvestment Ratio for Faron Pharmaceuticals Oy from None to None. For live market cap and broader valuation context, see market value of Faron Pharmaceuticals Oy.

Year Reinvestment Ratio Operating CF (GBX) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow